- +86 0371-86658258
- info@coreychem.com
English
| Product name | Nivolumab |
| Synonym | Nivolumab;BMS 936558;MDX 1106;ONO 4538;Opdivo;Nivolumab (anti-PD-1) |
| CAS NO. | 946414-94-4 |
| Appearance | Pale yellow to colourless liquid |
| Purity | ≥98% |
| MF | C6362H9862N1712O1995S42 |
| MW | 146kDa |
| Related categories | Chemical reagents |
| Transport Information | Not dangerous goods |
| Structural formula |  |
| Product Manager Email: | jessie@coreychem.com |
Therapeutic Applications in Oncology
It is primarily used in the treatment of various advanced or metastatic cancers.
Mechanism of Action
It works by blocking the PD-1 signaling pathway, thereby releasing the suppression of immune cells by tumor cells and reactivating the body’s immune system to attack cancer cells.
Product Manager Email：jessie@coreychem.com
10mg/bottle；
50mg/bottle；
100mg/bottle；
According to customer needs
